A Novel Treatment With Obinutuzumab-Chlorambucil in a Patient With B-Cell Prolymphocytic Leukemia: A Case Report and Review of the Literature

We report the case of a patient with B-cell prolymphocytic leukemia who was successfully treated with the novel humanized monoclonal antibody obinutuzumab. This patient was previously treated with the combination of rituximab and bendamustine and had recurrent infusion reactions. Her treatment with...

Full description

Bibliographic Details
Main Authors: Jason Hew MD, Dat Pham MD, Trevanne Matthews Hew MD, Vinay Minocha MD
Format: Article
Language:English
Published: SAGE Publishing 2018-07-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/2324709618788674